Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1β stimulated rheumatoid synovial fibroblasts

Leflunomide, an isoxazol derivative structurally unrelated to other immunomodulatory drugs, has proven to be efficacious in the treatment of rheumatoid arthritis (RA). This study was conducted to elucidate the mechanism by which leflunomide mediated antirheumatic effects. We investigated the effects...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: MIGITA, K, MIYASHITA, T, ISHIBASHI, H, MAEDA, Y, NAKAMURA, M, YATSUHASHI, H, IDA, H, KAWAKAMI, A, AOYAGI, T, KAWABE, Y, EGUCHI, K
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2004
Teme:
Clinical Studies
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1809130/
https://ncbi.nlm.nih.gov/pubmed/15320915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2004.02555.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items